Piper Jaffray Call Achillion (ACHN) a M&A Play Following Roche Buyout of Anadys
Go back to Piper Jaffray Call Achillion (ACHN) a M&A Play Following Roche Buyout of Anadys| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $15.10 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 504,330 | |||||
| Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) | Delayed: 3.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.70 | 52 Week High | $3.70 | |||
| Open | $26.00 | 52 Week Low | $0.60 | |||
| Day High | $3.70 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $-0.43 | |||
| Volume | 900 | |||||
